Article

The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccine

2024-04-22

Abstract excerpt

<title>Abstract</title> <p>There is currently no prophylactic vaccine available for human immunodeficiency virus (HIV). Research efforts have resulted in improved immunogens that mimic the native envelope (Env) glycoprotein structure. Recently, a novel triple tandem trimer (TTT) platform has been used to generate a plasmid encoding Env immunogen (pBG505-TTT) that expresses only as trimers, making it more suitable...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 202df56b-ebf2-5a39-accc-bd17b7e7a3c7
DOI: 10.21203/rs.3.rs-4139764/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccineDOI 10.21203/rs.3.rs-4139764/v1Read

Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus AnkaraSemantic proximity Read

HIV DNA Vaccine: Stepwise Improvements Make a DifferenceSemantic proximity Read

DNA vaccines: prime time is nowSemantic proximity Read

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteersSemantic proximity Read

Protection from viral rebound after therapeutic vaccination with an adjuvanted DNA vaccine is associated with SIV-specific polyfunctional CD8 T cells in the blood and mesenteric lymph nodesSemantic proximity Read

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineSemantic proximity Read

A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.Semantic proximity Read

DNA Vaccines Approach: From Concepts to ApplicationsSemantic proximity Read

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trialSemantic proximity Read

Engineering T Cells to Functionally Cure HIV-1 InfectionSemantic proximity Read

A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.Semantic proximity Read

Phase 1, dose-escalation trial of the safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies (DMAb) in healthy adultsSemantic proximity Read